Why the study?
Does cardiovascular magnetic resonance imaging improve risk stratification for incident coronary artery disease, atrial fibrillation, and heart failure in a population-based cohort?
Cohort (n=12,362)
No
Does cardiovascular magnetic resonance imaging improve risk stratification for incident coronary artery disease, atrial fibrillation, and heart failure in a population-based cohort?
Answers are grounded in this paper and cite their sources.
The Hamburg City Health Study will provide a large-scale, prospective evaluation of advanced CMR imaging biomarkers for predicting incident cardiovascular disease in a population-based cohort.
BACKGROUND: The purpose of this work is to describe the objectives and design of cardiovascular magnetic resonance (CMR) imaging in the single center, prospective, population-based Hamburg City Health study (HCHS). The HCHS aims at improving risk stratification for coronary artery disease (CAD), atrial fibrillation (AF) and heart failure (HF). METHODS: The HCHS will finally include 45,000 inhabitants of the city of Hamburg (Germany) between 45 and 74 years who undergo an extensive cardiovascular evaluation and collection of biomaterials. Risk-scores for CAD, AF and HF are used to create enriched subpopulations who are invited for CMR. A total number of approximately 12,362 subjects will undergo CMR and incident CAD, AF and HF will be assessed after 6 years follow-up. The standard CMR protocol includes cine-CMR, T1 and T2 mapping, aortic/mitral valve flow measurements, Late gadolinium enhancement, angiographies and measurements of aortic distensibility. A stress-perfusion scan is added in individuals at risk for CAD. The workflow of CMR data acquisition and analyses was evaluated in a pilot cohort of 200 unselected subjects. RESULTS: The obtained CMR findings in the pilot cohort agree with current reference values and demonstrate the ability of the established workflow to accomplish the objectives of HCHS. CONCLUSIONS: CMR in HCHS promises novel insights into major cardiovascular diseases, their subclinical precursors and the prognostic value of novel imaging biomarkers. The HCHS database will facilitate combined analyses of imaging, clinical and molecular data ("Radiomics").
No takes yet. Share an insight, caveat, or question.
Bohnen et al. (2018) conducted a cohort in Coronary artery disease, atrial fibrillation, and heart failure (n=12,362). Cardiovascular magnetic resonance (CMR) imaging was evaluated on Incident coronary artery disease, atrial fibrillation, and heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: